BSE Live
Nov 14, 16:01Prev. Close
130.10
Open Price
138.45
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:50Prev. Close
130.38
Open Price
129.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
130.46 (29)
| Cash Flow of Indo US Bio-Tech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 16.53 | 8.80 | 7.39 | 5.49 | 4.13 | |
| Net CashFlow From Operating Activities | 1.42 | -4.58 | 0.53 | 2.91 | 0.22 | |
| Net Cash Used In Investing Activities | -0.79 | 4.28 | -6.67 | -5.40 | -1.75 | |
| Net Cash Used From Financing Activities | -1.48 | 1.22 | 6.29 | 2.41 | 1.46 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.85 | 0.91 | 0.14 | -0.08 | -0.07 | |
| Cash And Cash Equivalents Begin of Year | 1.10 | 0.19 | 0.05 | 0.13 | 0.20 | |
| Cash And Cash Equivalents End Of Year | 0.25 | 1.10 | 0.19 | 0.05 | 0.13 |
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
13.08.2024
Indo US Bio-Tec Standalone June 2024 Net Sales at Rs 24.72 crore, up 29.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
13.08.2024
Indo US Bio-Tec Standalone June 2024 Net Sales at Rs 24.72 crore, up 29.12% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017